Key Takeaways
- Record EBITDA per tonne, cautious volume outlook: Q4 EBITDA per metric tonne hit an all-time high of Rs.25,400, driven by mix and recoveries, but volumes were muted as inflation cut into consumption.
- Specialty portfolio "got its mojo back": New specialty capex began yielding results, shifting the mix toward higher-margin ingredients and driving the margin expansion.
- AMET demand is the main drag: A fifth straight quarter of volume decline in Africa, Middle East, and Turkey, where currency devaluation and inflation have crushed consumption; recovery timing is unknown.
- FY23 is about risk management, not volume bets: Management declined to give volume or absolute EBITDA guidance, citing "nebulous" conditions, and anchored the year to an EBITDA-per-tonne band of Rs.16,000–18,000, trending toward the upper end.
- What to watch next quarter: Whether the China lockdowns reverse the Q4 logistics improvement, and whether the next three to four months reveal a demand recovery or a deeper cutback in India and the US.
The Quarter in Detail: Margin Surge, Volume Muted
- EBITDA per tonne jump: Q4 EBITDA per metric tonne reached ~Rs.25,000, the highest ever, driven by four factors: raw material price increases stabilizing at higher levels from December, eliminating the usual pass-through lag; logistics and freight cost increases tapering off with no backlog in recovery; certain contracts renegotiated with recoveries added to new pricing; and product mix improving as specialty ingredients constituted a larger share of the total portfolio.
- Gross profit per kg leap: Gross profit per kg rose to Rs.60 from Rs.44 in Q3, driven by new contracts and recoveries, mix improvement with specialty ingredients performing better, and strong performance from the US subsidiary TRI-K, aided by a robust US market and capacity expansion commissioned just before COVID.
- Volume growth tepid: Volume growth was muted, especially in surfactants, due to unprecedented inflation across the world impacting consumption. Tier-2 and Tier-3 customers reduced inventory and waited to see whether consumers would absorb the enhanced prices before buying normally. [10–11]
- India trajectory scaling down: India registered 9.4% volume growth for FY2022 but the trajectory has been scaling down every quarter; first signs of demand cutback are now visible in India.
- Downtrading mechanism: Downtrading does not impact Galaxy directly because it serves customers across all segments, but demand cutback can occur from habit changes, such as rural consumers reducing shampoo usage from three times a week to twice a week due to reduced disposable income.
- Small customers living hand-to-mouth: Small customers face cash problems because prices have risen significantly; they operate with lower inventory levels, living "seven days in a series."
Unnathan Shekhar: "What our sales people tell us is that the small customers problem is now cash because the prices have risen significantly they would have to work or manage their operations with a lower level of inventory, they cannot afford to have or maintain more inventory so they would possibly live for the day in a way of saying they live for seven days in a series."
Specialty Portfolio: The Margin Engine Fires Up
- Specialty recovery: The specialty portfolio "got its mojo back" with the opening of developed markets and the operationalization of new specialty capexes starting to yield results.
- TRI-K US performance: The US subsidiary did exceptionally well in Q4 with significantly better realizations and volumes; the expansion commissioned just before COVID helped capture opportunities.
- Capacity additions: Capacities commissioned on mild surfactants, nontoxic preservatives, and a proteins plant at TRI-K; the order of magnitude across all specialty additions is about 10,000 tons.
- Capex operationalization: Some of the FY22 capex projects have been operationalized; the remaining, including mild surfactants, nontoxic preservatives, and an R&D center and pilot plant in Tarapur, are to be operationalized by the end of Q1 FY23.
- Proteins portfolio: Volume is not significant but realizations are significant; a lot of work has been done over the last two years expanding the vegetable proteins range and capitalizing on opportunities over the last 18 months.
- Specialty capacity built for the long haul: Specialty capacity was built for a 7–8 year horizon; the first leg of growth was seen last year and the momentum will continue progressively.
Regional Deep-Dive: AMET Bleeds, Rest of World Bounces
- AMET volume decline: The entire Q4 volume decline is attributed to the performance surfactants business in Turkey and Egypt, where the inflationary scenario impacted consumption; these markets represent 50–55% of the AMET business.
- Fifth quarter of decline: This was the fifth quarter of volume decline; the first 6–8 months of FY22 saw severe supply-side constraints from global logistics; as supply improved, inflation and Egypt/Turkey devaluation started impacting demand.
- Rest of world bounce back: Driven by specialties; previously constrained by capacity, waiting for new capex operationalization, and outbound logistics, which improved in Q4 but may be reverting due to China lockdowns.
- AMET recovery timing unknown: Based on past experience, after currency depreciation it took six to nine months for consumers to adjust; management hopes it happens earlier but cannot make a statement, noting governments could provide stimulus.
- India demand vigilance: The situation is not as serious as Africa and the Middle East but management says it needs to be extremely vigilant and geared up.
K. Natarajan: "We do not have a crystal ball in terms of saying as to when things would improve, we only want to hope that it improves much earlier than what happened last."
Demand Environment: Inflation Is the Story
- Demand cutback mechanism: FMCG and home and personal care manufacturers reduced grammages to maintain magic price points, impacting volumes.
- COVID demand correction: Hand sanitization and hand wash demand corrected in the last year itself, but the hand-washing habit is sustainable; the hand wash market growth rate corrected from 30% during COVID times to 10–15%.
- Overall HPC volumes settled higher: The entire HPC category settled at a higher level than pre-COVID volumes; only the rate of growth is getting corrected.
- Near-term visibility window: The next three to four months will tell the story on how demand pans out; if the harvest is good and rural liquidity improves, demand may not be significantly impacted.
- Long-term industry outlook excellent: Management views current challenges as short-term blips and states the HPC industry is the best industry to be in, given the capabilities built over time.
K. Natarajan: "We cannot shift our focus saying that the HPC is not growing I will shift to the other industries that is something will be fraught with a huge amount of risk which we will never do because HPC industry is the best industry to be in, in terms of the way that we have build our capabilities, so these are short term blips, the long-term structure of this business and..."
Supply Chain & Raw Materials: A Fragile Improvement
- Q4 supply improvement: Raw material availability and logistics improved in Q4, but new challenges emerged from the Russia-Ukraine issue and stringent China lockdowns, complicating international logistics again.
- Outbound logistics reversal risk: Outbound logistics improved in Q4 but management is afraid it is reverting back to square one with the China lockdowns.
- Fatty alcohol price outlook: High season months are approaching; management expects things should start stabilizing and prices could start coming down as inventory levels go up, but too many moving parts prevent a clear judgment.
- Supply-chain normalization hope: Management hopes it will take about another two months for things to resolve themselves, assuming nothing new happens.
- Lauryl alcohol volatility: Price volatility in lauryl alcohol is expected to continue in coming years.
K. Natarajan: "First correction is the market is so volatile that we are not reading, we are only watching..."
Balance Sheet & Capital Allocation
- Working capital elevated: Higher monetary working capital is a function of higher price values, increased transit times, and raw material uncertainties forcing procurement from non-regular sources, resulting in advances; these are temporary factors and liquidity will release once they cease.
- Debt increase contained: Short-term debt rose because entire cash generation during the year went into working capital due to higher raw material prices; capex funding needs led to extra borrowing of up to Rs.90 Crores, but the debt-equity ratio remained at 0.22.
- FY22 capex: Rs.155 Crores spent on specialty products and certain performance products in Egypt and India, largely incurred on the Jhagadia project for the manufacture of mild surfactants and nontoxic preservatives, and on the R&D center and pilot plant in Tarapur.
- FY23 capex planned: Approximately Rs.150–200 Crores, to be used in similar areas: mild surfactants and nontoxic preservatives.
- Credit terms unchanged: No change in credit terms offered to customers.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA per metric tonne | Rs.16,000–18,000 band, trending toward upper end | FY23 |
| Capex | Rs.150–200 Crores on mild surfactants and nontoxic preservatives | FY23 |
| Specialty capex operationalization | Remaining projects (mild surfactants, nontoxic preservatives, R&D center/pilot plant) to be operationalized | End of Q1 FY23 |
| AMET recovery | Based on past experience, six to nine months after currency depreciation for consumer adjustment; management hopes earlier but no commitment | Unclear; wait and watch |
| Volume outlook | Management declined to hazard a guess, citing nebulous conditions; needs two to three months to assess | FY23–FY24 |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| Revenue | Not stated |
| EBITDA per metric ton | ₹25,400, highest quarterly, up from ₹12,000–₹13,000 a couple of quarters back |
| Gross profit per kg | ₹60, up from ₹44 in Q3 |
| EBITDA per metric ton guidance | ₹16,000 to ₹18,000, maintained; positive bias toward upper end of the band |
| India volume growth (FY22) | 9.4% |
| AMET volume decline (Q4) | 29%, on a base already declined 5% |
| Regional volume split (FY22) | India 37%, AMET 31%, Rest of World 32% |
| Home and personal care market global growth | minus 1% to 1% band |
| Fatty alcohol price | close to $2,800 per metric ton |
| Lauryl alcohol price swing (last year) | $2,100 to $3,200, back to $2,450, then to $2,800 |
| Specialty capacity addition | in the zone of about 10,000 tons (mild surfactants, nontoxic preservatives, other specialty care ingredients) |
| FY22 capex spent | ₹155 Crores |
| FY23 capex guidance | approximately ₹150 to ₹200 Crores |
| Short-term debt | about ₹290 Crores |
| Debt equity ratio | 0.22, unchanged |